Foundation date

February 2023


#Biotechnology / R&D Services


Therapeutic areas

Pharmaeconomica utilizes state-of-the-art computational techniques and a data-driven approach to streamline the drug discovery process. We excel in the pivotal stages of hit identification and hit-to-lead optimization. This is where science meets innovation, as we harness the potential of promising molecular structures and transform them into exceptional drug candidates.

With our team of skilled experts and cutting-edge computational techniques, we propel drug development forward, accelerating timelines and optimizing outcomes. By seamlessly integrating data-driven methodologies, we revolutionize the efficiency of the entire process. Trust in our expertise to take the drug discovery journey to new heights of success.

Upcoming events

Latest news

  • argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia

    20 hours ago

  • Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis

    Thursday November 16th 2023